Remove 2001 Remove FDA Remove Immunization
article thumbnail

Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics

PharmTech

In May 2024, the US Food and Drug Administration (FDA) approved Moderna’s next-generation base-modified mRNA-lipid nanoparticle (LNP) respiratory syncytial virus (RSV) vaccine mRESVIA (mRNA-1345) in adults aged 60 years and older with lower respiratory tract disease (5). Pfizer’s COVID-19 Vaccine Secures First Full FDA Approval.

article thumbnail

Premenstrual Disorders Linked With Increased Cardiovascular Disease Risk

Drug Topics

Data for the study was gathered from national registers in Sweden from 2001 to 2022. A team of investigators from the Institute of Environmental Medicine at the Karolinska Institutet conducted a cohort study to examine the association between premenstrual disorders and the subsequent risk of CVDs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Prescribing Red Flags, Corresponding Responsibility and DEA Investigations: What’s a Pharmacist To Do?

The FDA Law Blog

Mr. Houck was a diversion investigator with the Drug Enforcement Administration (“DEA”) in the field and at agency headquarters for 15 years before joining HPM in 2001. at this year’s American Pharmacists Association’s (“APhA’s”) Annual Meeting in Phoenix, March 24-27.

article thumbnail

PharmaShots Weekly Snapshots (April 03 - 07, 2023)

PharmaShots

TG Therapeutics Receives EMA’s CHMP Positive Opinion of Briumvi (ublituximab-xiiy) for the Treatment of Relapsing Forms of Multiple Sclerosis Date: Apr 3, 2023 | Tags: TG Therapeutics, Briumvi, Ublituximab-xiiy, Multiple Sclerosis, Regulatory, EMA, CHMP BMS Receives EMA’s CHMP Positive Opinion of Breyanzi (lisocabtagene maraleucel) for (..)

FDA 53
article thumbnail

Preliminary Injunction Decision in Chambers of Commerce Case Provides First Insights Into Merits of Medicare Negotiations Cases

The FDA Law Blog

Engler , a 2001 decision by the Sixth Circuit Court of Appeals. In any case, no Court can provide relief from economic harm that has already occurred because sovereign immunity bars the court from granting damages. Order at 24.

article thumbnail

OTC antiemetic medications: Relief for nausea and vomiting

The Checkup by Singlecare

Antihistamines work by blocking the effects of histamine , a chemical released by your body’s immune system. Kaopectate tablet and liquid suspension Bismuth subsalicylate is FDA-approved for treating nausea and vomiting. Sources: Central neurocircuitry associated with emesis , The American Journal of Medicine (2001).

Dosage 97
article thumbnail

Psychedelics, Pregnancy, and Breastfeeding

The Spirit Pharmacist

The only FDA approved treatment for post-partum depression is a progesterone analogue that must be delivered over a 60-hour IV infusion and appears mildly efficacious. Neurotoxicol Teratol, 2001. How Do Psychedelics Compare to Current Treatment Options? There are a couple notable advantages [1]. Clin Obstet Gynecol, 2019.